INTERNATIONAL PATENT: JANSSEN PHARMACEUTICA NV FILES APPLICATION FOR "ATP SYNTHASE INHIBITORS FOR USE IN THE TREATMENT OF NON-TUBERCULOSIS MYCOBACTERIA"

GENEVA, April 6 -- JANSSEN PHARMACEUTICA NV (Turnhoutseweg 302340 Beerse) filed a patent application (PCT/EP2024/077192) for "ATP SYNTHASE INHIBITORS FOR USE IN THE TREATMENT OF NON-TUBERCULOSIS MYCOBACTERIA" on Sep 27, 2024. With publication no. WO/2025/068448, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAHIRI, Sushmita Dipak (c/o Janssen Research & Development, LLC920 Route 202P.O Box 300Raritan, New Jersey 08869), VUONG, Cuong (c/o Janssen Pharmaceutica NVTurnhoutseweg 302340 Beerse), LANCKACKER, Ellen Anita (c/o ...